Acorda Therapeutics to Present at Deutsche Bank Health Care Conference.HAWTHORNE, N.Y. -- Acorda Therapeutics announced today that its President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Ron Cohen cohen or kohen (Hebrew: “priest”) Jewish priest descended from Zadok (a descendant of Aaron), priest at the First Temple of Jerusalem. The biblical priesthood was hereditary and male. , M.D., will present at the Deutsche Bank 30th Annual Health Care Conference in at the Hyatt Regency Hotel in Baltimore, Maryland on May 4, 2005. Event: Deutsche Bank 30th Annual Health Care Conference Presenter: Ron Cohen, M.D., President and CEO, Acorda Therapeutics Date: May 4, 2005 Time: 8:00 a.m. Eastern Time Location: Hyatt Regency Hotel, Baltimore, MD Room: Constellation Ballroom E A live webcast of the presentation can be accessed through http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker= W189786&item_id=1054170. (Due to its length, this URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.) The presentation will be also be available on Acorda's corporate site, located at http://www.acorda.com, within 24 hours of the presentation. Acorda Therapeutics, a privately-held biotechnology company, is developing therapies for spinal cord injury Spinal Cord Injury Definition Spinal cord injury is damage to the spinal cord that causes loss of sensation and motor control. Description Approximately 10,000 new spinal cord injuries (SCIs) occur each year in the United States. (SCI), multiple sclerosis (MS) and related nervous system disorders Nervous system disorders A satisfactory classification of diseases of the nervous system should include not only the type of reaction (congenital malformation, infection, trauma, neoplasm, vascular diseases, and degenerative, metabolic, toxic, or deficiency . The Company's marketed products include Zanaflex(R) Capsules, a short-acting drug indicated for the management of spasticity. For full prescribing information, please go to www.zanaflexcapsules.com. Acorda's lead clinical-stage product is Fampridine-SR, which is being developed for both MS and SCI. The Company's pipeline includes valrocemide, which it is developing with Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in , Ltd., as well as multiple preclinical products for regeneration and repair of the spinal cord and brain. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion